The Republican reconciliation bill offers large tax cuts for the wealthy but reduces healthcare subsidies and social safety net programs, negatively affecting middle- and lower-income Americans and increasing the uninsured population.
Comprehensive update on critical U.S. healthcare and insurance issues including Medicaid policy, rural hospital challenges, Medicare Advantage scrutiny, FDA drug approvals, and public health dynamics.
House Energy and Commerce Committee advances Republican Medicaid overhaul expected to cut federal spending by $625 billion, introduce work requirements, and impact 10 million Americans' coverage.
New analysis shows Inflation Reduction Act provisions will reduce Medicare Part D out-of-pocket costs for specialty drugs etanercept, ustekinumab, and ibrutinib, improving affordability for beneficiaries.
Explore how the Affordable Care Act reshaped U.S. healthcare marketing and strategy over 15 years, emphasizing consumer focus, digital innovation, and value-based care.
The proposed $715 billion Medicaid cuts in the federal budget reconciliation bill could result in 13.7 million losing coverage nationwide, severely impacting Wisconsin's healthcare access and Medicaid administration.
Explore how proposed Medicaid cuts and new work requirements may affect over 17 million older Americans. Understand the potential policy impacts on eligibility, coverage, and healthcare access.
The House Ways and Means committee conducted an unprecedented marathon markup session exceeding 18 hours to debate President Trump's comprehensive tax and healthcare bill, including critical Medicaid and ACA amendments. This intense legislative process highlights challenges in shaping U.S. healthcare and tax policy.
Cutting Medicaid funding shifts costs to Medicare, increasing federal spending and reducing access to care. Learn how Medicaid supports Medicare affordability and prevents costly hospitalizations.
Analysis of inflation rebate implementation under the Inflation Reduction Act highlights the need to include Medicare Advantage enrollees to maximize drug cost savings and deter pharmaceutical price hikes.
